The Market Herald - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • U.K.-based telehealth company Doctor Care Anywhere (DOC) has signed a new channel agreement with one of the world’s largest insurance and assistance companies, Allianz Partners
  • This is the company’s first international private medical insurance (iPMI) agreement in Europe, following the expansion of its offering to the Republic of Ireland in October
  • Under the agreement, Allianz European policyholders and dependents will have access to DOC’s digital health services, including virtual GP consultations
  • Doctor Care anywhere is set to launch its services with Allianz in January 2021
  • On the market this afternoon, DOC is up 5.42 per cent and is trading at $1.27 per share

Doctor Care Anywhere (DOC) has signed a new channel agreement with one of the world’s largest insurance and assistance companies, Allianz Partners.

This is the company’s first international private medical insurance (iPMI) agreement in Europe, following the expansion of its offering to the Republic of Ireland in October.

The agreement will allow Allianz iPMI policyholders and dependents, based in Europe, access to DOC’s digital health services, including teleconsultation.

Doctor Care anywhere is set to launch its services with Allianz in January 2021 and the agreement will carry no set expiry period.

“We are thrilled by the opportunity to work with another world-leading insurer; this is further recognition of the value that the Doctor Care Anywhere platform brings to patients, payors and providers,” founder and CEO Dr Bayju Thakar said.

“Being engaged by Allianz Partners adds to the company’s growth trajectory and supports our ability to service patient needs globally. This agreement is integral to our strategic plans for 2021 and beyond, helping us to deliver joined-up, accessible, quality health and disease care in the U.K. and globally,” he added.

DOC only recently listed on the Australian Securities Exchange (ASX) on December 4.

On the market this afternoon, DOC is up 5.42 per cent and is trading at $1.27 per share at 1:10 pm AEDT.

DOC by the numbers
More From The Market Herald

Cynata Therapeutics receives approval to launch phase two trial of CYP-001 in Turkey

Cell therapy company, Cynata Therapeutics (ASX:CYP) has received regulatory and ethics approval to commence a phase…

Little Green Pharma positions itself for growth in France’s emerging medicinal cannabis market

Little Green Pharma (ASX:LGP) is primed for substantial growth after a major amendment to the French…

PolyNovo posts $8m sales month and $9m revenue month for November

Disruptive medical device company PolyNovo (ASX:PNV) has announced record monthly sales of $8.8 million for November…
Imugene (ASX:IMU) - Managing Director & CEO, Leslie Chong

Imugene set to secure European patent for cancer vaccine; announces new phase II CRC cancer trial in 2024

Imugene (ASX:IMU) is on the verge of securing approval from the European Patent Office (EPO) for…